FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称PELUNTAMIG
异名/同义词BISPECIFIC ANTIBODY AGAINST DLL3 AND CD47
H-GAMMA1 HEAVY CHAIN ANTI-CD47 (1-444) (VH (HOMO SAPIENS IGHV1-46*01 (88.7%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT (8.8.7) (26-33.51-58.97-103)) (1-114) -HOMO SAPIENS IGHG1*01 G1M17,1 CH1 K120, CH3 D12, L14, G1V74 CH3 C10, G1V32 CH3 W22 (KNOB) (CH1 K120 (211) (115-212), HINGE 1-15 (213-227), CH2 (228-337), CH3 S10>C (351), D12 (353), L14 (355), T22>W (363) (338-442), CHS (443-444)) (115-444)), (217-214')- DISULFIDE WITH COMMON L-KAPPA LIGHT CHAIN (1'-214') (V-KAPPA (HOMO SAPIENS IGKV3-20*01 (84.4%) -IGKJ1*01 (91.7%), CDR-IMGT (6.3.9) (27'-32'.50'-52'.89'-97')) (1'-107') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (153'), V101 (191')) (108'-214'));
IMMUNOGLOBULIN G1 (350-CYSTEINE,367-SERINE,369-ALANINE,408-VALINE), ANTI-(HUMAN NOTCH LIGAND DLL3) (HUMAN-MUS MUSCULUS MONOCLONAL PT217 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL PT217 .KAPPA.-CHAIN, (227->223'),(230->226'),(350->351')-TRIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 (351-CYSTEINE,363-TRYPTOPHAN) ANTI-(HUMAN CD47 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL PT217 .GAMMA.1-CHAIN) DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL PT217 .KAPPA.-CHAIN
IMMUNOGLOBULIN H-GAMMA1_L-KAPPA, ANTI-(HOMO SAPIENS CD47 (CD47 MOLECULE, INTEGRIN ASSOCIATED PROTEIN, IAP, MER6, OA3) AND ANTI-(HOMO SAPIENS DLL3 (DELTA-LIKE LIGAND 3, DELTA LIKE CANONICAL NOTCH LIGAND 3)), BISPECIFIC;
PELUNTAMIG
PELUNTAMIG [INN]
PELUNTAMIG [USAN]
PT217
PT-217
CAS登记号2928515-21-1
物质唯一标识(Unique Ingredient Identifier)4A6ZWS8R8E
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System